These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11082389)

  • 1. Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized?
    Pouzet B; Vilquin JT; Hagège AA; Scorsin M; Messas E; Fiszman M; Schwartz K; Menasché P
    Circulation; 2000 Nov; 102(19 Suppl 3):III210-5. PubMed ID: 11082389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors?
    Pouzet B; Ghostine S; Vilquin JT; Garcin I; Scorsin M; Hagège AA; Duboc D; Schwartz K; Menasché P
    Circulation; 2001 Sep; 104(12 Suppl 1):I223-8. PubMed ID: 11568060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function.
    Scorsin M; Hagège A; Vilquin JT; Fiszman M; Marotte F; Samuel JL; Rappaport L; Schwartz K; Menasché P
    J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1169-75. PubMed ID: 10838534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction.
    Ghostine S; Carrion C; Souza LC; Richard P; Bruneval P; Vilquin JT; Pouzet B; Schwartz K; Menasché P; Hagège AA
    Circulation; 2002 Sep; 106(12 Suppl 1):I131-6. PubMed ID: 12354722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting functional outcome after autologous skeletal myoblast transplantation.
    Pouzet B; Vilquin JT; Hagège AA; Scorsin M; Messas E; Fiszman M; Schwartz K; Menasché P
    Ann Thorac Surg; 2001 Mar; 71(3):844-50; discussion 850-1. PubMed ID: 11269463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy.
    Dib N; McCarthy P; Campbell A; Yeager M; Pagani FD; Wright S; MacLellan WR; Fonarow G; Eisen HJ; Michler RE; Binkley P; Buchele D; Korn R; Ghazoul M; Dinsmore J; Opie SR; Diethrich E
    Cell Transplant; 2005; 14(1):11-9. PubMed ID: 15789658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.
    Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor.
    Gmeiner M; Zimpfer D; Holfeld J; Seebacher G; Abraham D; Grimm M; Aharinejad S
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1238-45. PubMed ID: 21329947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft.
    Tambara K; Premaratne GU; Sakaguchi G; Kanemitsu N; Lin X; Nakajima H; Sakakibara Y; Kimura Y; Yamamoto M; Tabata Y; Ikeda T; Komeda M
    Circulation; 2005 Aug; 112(9 Suppl):I129-34. PubMed ID: 16159804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up.
    Gavira JJ; Herreros J; Perez A; Garcia-Velloso MJ; Barba J; Martin-Herrero F; Cañizo C; Martin-Arnau A; Martí-Climent JM; Hernández M; López-Holgado N; González-Santos JM; Martín-Luengo C; Alegria E; Prósper F
    J Thorac Cardiovasc Surg; 2006 Apr; 131(4):799-804. PubMed ID: 16580437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded human cord blood-derived endothelial progenitor cells salvage infarcted myocardium in rats with acute myocardial infarction.
    Hu CH; Li ZM; Du ZM; Zhang AX; Rana JS; Liu DH; Yang DY; Wu GF
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):551-6. PubMed ID: 20529094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat.
    Al Attar N; Carrion C; Ghostine S; Garcin I; Vilquin JT; Hagège AA; Menasché P
    Cardiovasc Res; 2003 Apr; 58(1):142-8. PubMed ID: 12667955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction.
    Ince H; Petzsch M; Rehders TC; Chatterjee T; Nienaber CA
    J Endovasc Ther; 2004 Dec; 11(6):695-704. PubMed ID: 15615560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up.
    Smits PC; van Geuns RJ; Poldermans D; Bountioukos M; Onderwater EE; Lee CH; Maat AP; Serruys PW
    J Am Coll Cardiol; 2003 Dec; 42(12):2063-9. PubMed ID: 14680727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections.
    Hamdi H; Planat-Benard V; Bel A; Puymirat E; Geha R; Pidial L; Nematalla H; Bellamy V; Bouaziz P; Peyrard S; Casteilla L; Bruneval P; Hagège AA; Agbulut O; Menasché P
    Cardiovasc Res; 2011 Aug; 91(3):483-91. PubMed ID: 21565832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of electrostimulation with cell transplantation in ischemic heart disease.
    Shafy A; Lavergne T; Latremouille C; Cortes-Morichetti M; Carpentier A; Chachques JC
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):994-1001. PubMed ID: 19660354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium.
    Farahmand P; Lai TY; Weisel RD; Fazel S; Yau T; Menasche P; Li RK
    Circulation; 2008 Sep; 118(14 Suppl):S130-7. PubMed ID: 18824744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium.
    Agbulut O; Vandervelde S; Al Attar N; Larghero J; Ghostine S; Léobon B; Robidel E; Borsani P; Le Lorc'h M; Bissery A; Chomienne C; Bruneval P; Marolleau JP; Vilquin JT; Hagège A; Samuel JL; Menasché P
    J Am Coll Cardiol; 2004 Jul; 44(2):458-63. PubMed ID: 15261948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic pretreatment to enhance myocardial function after cellular cardiomyoplasty with skeletal myoblasts.
    Retuerto MA; Beckmann JT; Carbray J; Patejunas G; Sarateanu S; Kane BJ; Smulevitz B; McPherson DD; Rosengart TK
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):478-484.e2. PubMed ID: 17258586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?
    Pouly J; Hagège AA; Vilquin JT; Bissery A; Rouche A; Bruneval P; Duboc D; Desnos M; Fiszman M; Fromes Y; Menasché P
    Circulation; 2004 Sep; 110(12):1626-31. PubMed ID: 15364802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.